Two-Dose Vaccination Significantly Prolongs the Duration from Symptom Onset to Death: A Retrospective Study Based on 173,894 SARS-CoV-2 Cases in Khyber Pakhtunkhwa, Pakistan

Qianqian Song, Naseem Asghar, Ata Ullah, Baosheng Liang, Mengping Long, Taobo Hu, Xiao‐Hua ZhouInternational Journal of Environmental Research and Public Health 2022 · DOI

TL;DR

This study analyzed over 173,000 COVID-19 cases in Pakistan to understand the duration from symptom onset to recovery or death (SOR/SOD) and identify influencing factors. A key finding is that two-dose COVID-19 vaccination significantly prolongs the time from symptom onset to death, suggesting a potential benefit in delaying severe outcomes, even in breakthrough infections.

What Problem Does This Paper Address?

As the COVID-19 pandemic evolved, understanding the temporal progression of the disease, from symptom onset to recovery or death, became crucial for public health interventions and resource allocation. While early studies focused on case fatality rates and risk factors, there was a need for more detailed analysis of the duration of these outcomes, particularly in the context of emerging SARS-CoV-2 variants and widespread vaccination campaigns. Specifically, this paper aims to quantify the Symptom Onset to Recovery (SOR) and Symptom Onset to Death (SOD) periods in Khyber Pakhtunkhwa, Pakistan, and to investigate how factors like age, comorbidities, and crucially, vaccination status, influence these durations. This information is vital for predicting disease trajectory, understanding the impact of interventions, and informing public health strategies.

Methods

The researchers employed a retrospective cohort study design, analyzing a large dataset of 173,894 confirmed COVID-19 cases from March 2020 to November 2021 in Khyber Pakhtunkhwa, Pakistan.

Key methodological aspects include:

  • Survival Analysis: The core of the analysis involved fitting parametric survival models (Weibull, Gamma, log-normal, and log-logistic) to estimate the distributions of SOR and SOD. The best-fitting model was selected using the Akaike Information Criterion (AIC).
  • Accelerated Failure Time (AFT) Models: These models were used to identify factors associated with the length of SOR and SOD. Odds Ratios (OR) and Hazard Ratios (HR) with 95% Confidence Intervals (CIs) were calculated to quantify the effect of various characteristics.
  • Propensity Score Matching (PSM): To address potential confounding and compare groups more rigorously, PSM was used. This included 1:1 matching by gender and age for the Alpha and Delta periods, and multiple PSM to match cases with different vaccine doses (zero, one, or two) across various periods.
  • Statistical Software: The analysis was conducted using R (version 4.2.0) with specific packages for survival analysis and data visualization.

Datasets

The primary dataset used in this study was acquired from the Directorate General Health Services (KP), Pakistan. This dataset comprises all hospital attendance records reported from all districts of the Khyber Pakhtunkhwa province for confirmed SARS-CoV-2 cases between March 16, 2020, and November 30, 2021. It includes demographic information, symptom details, comorbidities, vaccination status, and patient outcomes (active, recovered, or deceased).

Key Insights and Ideas

  • Vaccination as a "Time Buyer": The most striking finding is that individuals who received two doses of a COVID-19 vaccine had a significantly longer duration from symptom onset to death compared to unvaccinated individuals. This suggests that vaccination, even in the event of breakthrough infection, may delay the progression to a fatal outcome, providing more time for potential interventions or natural recovery.
  • Age and Comorbidities Remain Critical: As expected, older age and the presence of comorbidities like cardiovascular diseases, chronic lung disease, and diabetes were associated with shorter SOD, highlighting their continued importance as risk factors for severe outcomes.
  • Home Quarantine as a Protective Factor (for SOD): Interestingly, home quarantine was found to be significantly associated with a longer SOD. This could be interpreted as individuals adhering to quarantine measures, potentially seeking medical attention later or having milder initial symptoms that don't necessitate immediate hospitalization, thus delaying the recorded death.
  • ICU Admission Accelerates Death: Conversely, ICU admission was associated with a significantly shorter SOD, indicating that critical illness requiring intensive care is a strong predictor of a rapid progression to death.
  • Gender Differences Persist: While males had a higher case fatality rate (CFR) in the early stages, the study found that males were associated with a longer SOD. This nuanced finding warrants further investigation into gender-specific disease trajectories.

Key Results

  • Overall SOR/SOD: The estimated median SOR was 17.0 days, and the median SOD was 9.5 days for all cases.
  • ICU vs. Non-ICU: ICU cases had a longer median SOR (27.6 days) but a shorter median SOD (6.9 days) compared to non-ICU cases (SOR: 17.0 days, SOD: 8.4 days).
  • Alpha vs. Delta: The Delta period saw slightly shorter SOR and SOD compared to the Alpha period.
  • Vaccination Impact on SOD:
    • Unvaccinated cases had the shortest median SOD (9.1 days).
  • Cases with one vaccine dose had a median SOD of 9.4 days.
  • Cases with two vaccine doses had the longest median SOD (11.2 days). This difference was statistically significant.
  • Risk Factors for Shorter SOD: Age (older cases had shorter SOD), fever, breathing issues, and ICU admission were associated with shorter SOD.
  • Factors for Longer SOD: Male gender, sore throat, headache, obesity, and home quarantine were associated with longer SOD.

Limitations and Future Work

The authors acknowledge several limitations:

  • Hospitalization Duration: The study could not assess the effect of vaccine dose on hospitalization length due to missing admission date information.
  • Missing Vaccination Data: A significant portion of cases had missing vaccination status, which was excluded from the analysis, potentially introducing bias.
  • Variant Determination: Alpha and Delta variants were identified based on news reports and time periods, not genetic sequencing, which could lead to misclassification.

Future work could focus on:

  • Investigating the specific mechanisms by which two-dose vaccination prolongs SOD, potentially through immune responses or delayed viral clearance.
  • Further exploring the gender-specific differences in COVID-19 outcomes.
  • Analyzing the impact of different vaccine types and booster doses on SOR/SOD.
  • Integrating hospitalization data to provide a more comprehensive picture of disease progression.

Summary updated

Abstract

This research was carried out to quantify the duration from symptom onset to recovery/death (SOR/SOD) during the first four waves and the Alpha/Delta period of the epidemic in Khyber Pakhtunkhwa, Pakistan, and identify the associated factors. A total of 173,894 COVID-19 cases were admitted between 16 March 2020 and 30 November 2021, including 458 intensive care unit (ICU) cases. The results showed that the case fatality rate (CFR) increased with age, and females had a higher CFR. The median SOR of ICU cases was longer than that of non-ICU cases (27.6 vs. 17.0 days), while the median SOD was much shorter (6.9 vs. 8.4 days). The SOR and SOD in the Delta period were slightly shortened than the Alpha period. Age, cardiovascular diseases, chronic lung disease, diabetes, fever, breathing issues, and ICU admission were risk factors that were significantly associated with SOD (<i>p</i> < 0.001). A control measure, in-home quarantine, was found to be significantly associated with longer SOD (odds ratio = 9.49, <i>p</i> < 0.001). Infected vaccinated individuals had longer SOD than unvaccinated individuals, especially for cases that had received two vaccine doses (<i>p</i> < 0.001). Finally, an advice on getting full-dose vaccination is given specifically to individuals aged 20-59 years.
BibTeX
@article{song2022two,
  author = {Qianqian Song and Naseem Asghar and Ata Ullah and Baosheng Liang and Mengping Long and Taobo Hu and Xiao‐Hua Zhou},
  title = {{Two-Dose Vaccination Significantly Prolongs the Duration from Symptom Onset to Death: A Retrospective Study Based on 173,894 SARS-CoV-2 Cases in Khyber Pakhtunkhwa, Pakistan}},
  journal = {International Journal of Environmental Research and Public Health},
  year = {2022},
  doi = {10.3390/ijerph191811531},
}
Figure